EUVIMEDEUVIMED entdecken
Crossref

Updated genetic testing in individuals with unexplained adenomatous polyposis and the diagnostic yield

Blake Rowell, Maegan E Roberts, Pamela L Brock, Julia Cooper, Rachel Pearlman, Matthew F Kalady, Stacey Culp, Peter P Stanich, Josie Baker

Familial Cancer · 2025

DOI: 10.1007/s10689-025-00513-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, 2025. Verfasst von Blake Rowell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Genetics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Adenomatous Polyposis Coli, Genetic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic testing advancements have improved detection of hereditary polyposis syndromes. Many individuals with unexplained adenomatous polyposis previously underwent limited genetic testing and may benefit from updated testing to identify underlying hereditary polyposis syndromes. We aimed to evaluate the yield of updated testing in adenomatous polyposis cases with previously negative germline genetic testing. Individuals with adenomatous polyposis with uninformative genetic testing prior to 2016 and subsequent updated multi-gene panel testing were analyzed. The updated multi-gene panel testing included the currently recommended 12 polyposis-associated genes. Twenty-one individuals met study criteria. Updated genetic testing identified pathogenic variants (PV) in 6/21 (29%) with four (19%) of the PVs associated with a polyposis phenotype (APC [× 2], AXIN2, and biallelic PMS2) and two (10%) were associated with other cancer predisposition syndromes (ATM and RAD51C). Although APC was included in the initial testing for the two patients found to have APC PVs, the previously completed deletion/duplication analysis did not include the 5' untranslated region. Updated genetic testing in individuals with unexplained polyposis had a very high yield and identified previously undetected PVs. Updated testing enabled more accurate diagnoses and personalized surveillance recommendations as well as identification of at-risk relatives. Given the improved diagnostic yield, it is crucial to consider genetic testing for individuals with unexplained polyposis who have previously undergone limited testing, due to small gene lists and/or outdated technology, ensuring alignment with current standards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenomatous Polyposis ColiGenetic TestingHumansMaleFemaleAdultMiddle AgedGenetic Predisposition to DiseaseYoung AdultGerm-Line MutationAgedAdenomatous Polyposis Coli Protein

Stichwörter der Autor:innen

APCAdenomatous polyposisColonic polyposis of unknown etiologyDiagnostic yieldIdiopathic adenomatous polyposisPanel testing

Substanzen

Adenomatous Polyposis Coli ProteinAPC protein, human

Autor:innen und Institutionen

  • Center for Human Genetics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Division of Colon and Rectal Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Department of Biomedical Informatics, Center for Biostatistics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Josie.Baker@osumc.edu.

Zitieren

APA

Rowell, B., Roberts, M. E., Brock, P. L., Cooper, J., Pearlman, R., Kalady, M. F., Culp, S., Stanich, P. P., & Baker, J. (2025). Updated genetic testing in individuals with unexplained adenomatous polyposis and the diagnostic yield. Familial Cancer. https://doi.org/10.1007/s10689-025-00513-4

Vancouver

Rowell B, Roberts ME, Brock PL, Cooper J, Pearlman R, Kalady MF, et al. Updated genetic testing in individuals with unexplained adenomatous polyposis and the diagnostic yield. Familial Cancer. 2025. doi:10.1007/s10689-025-00513-4

BibTeX
@article{Rowell2025,
  author = {Rowell, Blake and Roberts, Maegan E and Brock, Pamela L and Cooper, Julia and Pearlman, Rachel and Kalady, Matthew F and Culp, Stacey and Stanich, Peter P and Baker, Josie},
  title = {Updated genetic testing in individuals with unexplained adenomatous polyposis and the diagnostic yield},
  journal = {Familial Cancer},
  year = {2025},
  doi = {10.1007/s10689-025-00513-4}
}
Kostenlos starten →